Attached files

file filename
EX-32.2 - EX. 32.2 - Oraco Resources, Inc.ex32-2.htm
EX-31.1 - EX. 31.1 - Oraco Resources, Inc.ex31-1.htm
EX-31.2 - EX. 31.2 - Oraco Resources, Inc.ex31-2.htm
EX-32.1 - EX. 32.1 - Oraco Resources, Inc.ex32-1.htm




UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

Form 10-Q/A
(Amendment No. 1)

x  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2011

¨  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number 333-167607

ORACO RESOURCES, INC.
(Exact name of registrant as specified in its charter)

Nevada
 
27-2300414
(State or other jurisdiction of incorporation or organization)
 
(I.R.S. Employer Identification No.)

605 West Knox Road, Suite 102, Tempe, AZ.
 
85284
(Address of principal executive offices)
 
(Zip Code)

(480) 588-3333
(Registrant’s telephone number, including area code)

Copies of Communications to:
Stoecklein Law Group
Emerald Plaza
402 West Broadway
Suite 690
San Diego, CA 92101
(619) 704-1310
Fax (619) 704-0556

Indicate by check mark whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes x    No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes x    No ¨

 
1

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Ruble 12b-2 of the Exchange Act.

Large accelerated filer  ¨
Accelerated filer  ¨
   
Non-accelerated filer  ¨ (Do not check if a smaller reporting company)
Smaller reporting company  x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes x     No ¨

The number of shares of Common Stock, $0.001 par value, outstanding on May 13, 2011 was 15,344,000 shares.

*EXPLANATORY NOTE –The Registrant is amending this Form 10-Q to indicate that it is a shell company by checking the shell box on the cover page; and (ii) revise its “disclosure controls and procedures” disclosure under Item 4T to include and refer to the full definition of “disclosure controls and procedures” as defined in Rule 13a-15(e) of the Exchange Act. No other disclosure was changed.



 
2

 

ORACO RESOURCES, INC.
 
FORMERLY STERILITE SOLUTIONS CORP.
 
(A DEVELOPMENT STAGE COMPANY)
 
BALANCE SHEETS
 
             
             
   
March 31,
   
December 31,
 
   
2011
   
2010
 
ASSETS
 
(unaudited)
   
(audited)
 
             
Current assets:
           
Cash
  $ 31     $ 93  
Total current assets
    31       93  
                 
Other assets:
               
Fixed assets, net
    6,774       1,736  
Trademark
    975       975  
Website, net
    188       208  
Total other assets
    7,937       2,919  
                 
Total assets
  $ 7,968     $ 3,012  
                 
                 
LIABILITIES AND STOCKHOLDERS' DEFICIT
               
                 
Current liabilities:
               
Accounts payable
  $ -     $ 20,626  
Accrued interest payable - related party
    214       88  
Total current liabilities
    214       20,714  
                 
Long term liabilities:
               
Line of credit - related party
    10,000       4,000  
 
    10,000       4,000  
                 
Total liabilities
    10,214       24,714  
                 
Stockholders' deficit:
               
Preferred stock, $0.001 par value, 10,000,000 shares
               
authorized, no shares issued and outstanding
    -       -  
Common stock, $0.001 par value, 100,000,000 shares
               
authorized, 15,344,000 and 10,544,000 shares issued and outstanding
               
as of March 31, 2011 and December 31, 2010, respectively
    15,344       10,544  
Additional paid-in capital
    63,956       8,756  
Common stock payable
    700       -  
Deficit accumulated during development stage
    (82,246 )     (41,002 )
Total stockholders' deficit
    (2,246 )     (21,702 )
                 
Total liabilities and stockholders' deficit
  $ 7,968     $ 3,012  

See Accompanying Notes to Financial Statements.

 
3

 


ORACO RESOURCES, INC.
 
FORMERLY STERILITE SOLUTIONS CORP.
 
(A DEVELOPMENT STAGE COMPANY)
 
STATEMENTS OF OPERATIONS
 
             
             
   
For the
   
Inception
 
   
three months
   
(April 6, 2010)
 
   
ended
   
to
 
   
March 31,
   
March 31,
 
   
2011
   
2011
 
   
(unaudited)
   
(unaudited)
 
             
Revenue
  $ -     $ -  
                 
Operating expenses:
               
Depreciation and amortization
    637       1,061  
General and administrative
    149       2,082  
Professional fees
    40,337       78,894  
Total operating expenses
    41,123       82,037  
                 
Loss from operations
    (41,123 )     (82,037 )
                 
Other expense:
               
Interest income
    5       5  
Interest expense - related party
    (126 )     (214 )
Total other expense
    (121 )     (209 )
                 
Net loss
  $ (41,244 )   $ (82,246 )
                 
                 
Weighted average number of common shares
    12,784,000          
outstanding - basic
               
                 
Net loss per share - basic
  $ (0.00 )        

See Accompanying Notes to Financial Statements.

 
4

 


ORACO RESOURCES, INC.
 
FORMERLY STERILITE SOLUTIONS CORP.
 
(A DEVELOPMENT STAGE COMPANY)
 
STATEMENTS OF CASH FLOWS
 
             
   
For the
   
Inception
 
   
three months
   
(April 6, 2010)
 
   
ended
   
to
 
   
March 31,
   
March 31,
 
   
2011
   
2011
 
   
(unaudited)
   
(unaudited)
 
CASH FLOWS FROM OPERATING ACTIVITIES
           
Net loss
  $ (41,244 )   $ (82,246 )
Adjustments to reconcile net loss
               
to net cash used in operating activities:
               
Shares issued for services
    -       6,800  
Depreciation and amortization
    637       1,061  
Changes in operating assets and liabilities:
               
(Decrease) in accounts payable
    (20,626 )     -  
Increase in accrued interest payable
    126       214  
                 
Net cash used in operating activities
    (61,107 )     (74,171 )
                 
CASH FLOWS FROM INVESTING ACTIVITIES
               
Purchase of furniture and equipment
    (5,376 )     (7,494 )
Purchase computer software
    (279 )     (279 )
Purchase of trademark
    -       (975 )
Purchase of website development
    -       (250 )
                 
Net cash used in investing activities
    (5,655 )     (8,998 )
                 
CASH FLOWS FROM FINANCING ACTIVITIES
               
Proceeds from notes payable - related party
    6,000       10,000  
Proceeds from sale of common stock, net of offering costs
    60,000       72,500  
Proceeds from sale of common stock payable, net of offering costs
    700       700  
                 
Net cash provided by financing activities
    66,700       83,200  
                 
NET CHANGE IN CASH
    (62 )     31  
                 
CASH AT BEGINNING OF YEAR
    93       -  
                 
CASH AT END OF YEAR
  $ 31     $ 31  
                 
SUPPLEMENTAL INFORMATION:
               
Interest paid
  $ -     $ -  
Income taxes paid
  $ -     $ -  
                 
Non-cash activities:
               
Number of shares issued for services
    -       68,000  

See Accompanying Notes to Financial Statements.

 
5

 

ORACO RESOURCES, INC.
FORMERLY STERILITE SOLUTIONS CORP.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO FINANCIAL STATEMENTS

NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of presentation
The interim financial statements included herein, presented in accordance with United States generally accepted accounting principles and stated in US dollars, have been prepared by the Company, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures are adequate to make the information presented not misleading.
 
These statements reflect all adjustments, consisting of normal recurring adjustments, which in the opinion of management, are necessary for fair presentation of the information contained therein. It is suggested that these condensed interim financial statements be read in conjunction with the financial statements of the Company for the period of Inception (April 6, 2010) to December 31, 2010 and notes thereto included in the Company’s 10-K annual report and all amendments. The Company follows the same accounting policies in the preparation of interim reports.
 
Results of operations for the interim period are not indicative of annual results.

Organization
On February 23, 2011, the Company amended its articles of incorporation and changed its name to Oraco Resources, Inc.

Use of estimates
The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ significantly from those estimates.

Cash and cash equivalents
For the purpose of the statements of cash flows, all highly liquid investments with an original maturity of three months or less are considered to be cash equivalents. The carrying value of these investments approximates fair value.


 
6

 

Fixed assets
Property and equipment are recorded at cost.  Expenditures for major additions and improvements are capitalized and minor replacements, maintenance, and repairs are charged to expense as incurred.  When property and equipment are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period.  Depreciation is provided over the estimated useful lives of the related assets using the straight-line method for financial statement purposes.  The Company uses other depreciation methods (generally accelerated) for tax purposes where appropriate.  The estimated useful lives for significant property and equipment categories are as follows:

Computer equipment                                        3 years
Computer software                                           1 year

The Company reviews the carrying value of property, plant and equipment for impairment whenever events and circumstances indicate that the carrying value of an asset may not be recoverable from the estimated future cash flows expected to result from its use and eventual disposition.  In cases where undiscounted expected future cash flows are less than the carrying value, an impairment loss is recognized equal to an amount by which the carrying value exceeds the fair value of assets.  The factors considered by management in performing this assessment include current operating results, trends and prospects, the manner in which the property is used, and the effects of obsolescence, demand, competition and other economic factors.  Based on this assessment there was no impairment as March 31, 2011.

Trademarks
ASC 350 requires that goodwill and intangible assets with indefinite useful lives no longer be amortized, but instead tested for impairment at least annually in accordance with the provisions of ASC 350. This standard also requires that intangible assets with definite useful lives be amortized over their respective estimated useful lives to their estimated residual values, and reviewed for impairment. As of March 31, 2011, the Company believes there is no impairment of its intangible assets.

 
The Company's intangible assets consist of the costs of filing and acquiring various trademarks. The trademarks are recorded at cost. The Company determined that the trademarks have an estimated useful life of 10 years and will be reviewed annually for impairment.  Amortization will be recorded over the estimated useful life of the assets using the straight-line method for financial statement purposes. The Company will commence amortization once the economic benefits of the assets begin to be consumed and they plan to record amortization once production begins and the related revenues are recorded.

Website
The Company capitalizes the costs associated with the development of the Company’s website pursuant to ASC Topic 350.  Other costs related to the maintenance of the website are expensed as incurred.  Amortization is provided over the estimated useful lives of 3 years using the straight-line method for financial statement purposes.   The Company has commenced amortization upon completion of the Company’s fully operational website.  Amortization expense for the three months ended March 31, 2011 was $21.


 
7

 

Stock-based compensation
The Company records stock based compensation in accordance with the guidance in ASC Topic 505 and 718 which requires the Company to recognize expense related to the fair value of its employee stock option awards.  This eliminates accounting for share-based compensation transactions using the intrinsic value and requires instead that such transactions be accounted for using a fair-value-based method. The Company recognizes the cost of all share-based awards on a graded vesting basis over the vesting period of the award.

Earnings per share
The Company follows ASC Topic 260 to account for the earnings per share. Basic earning per common share (“EPS”) calculations are determined by dividing net income by the weighted average number of shares of common stock outstanding during the year. Diluted earning per common share calculations are determined by dividing net income by the weighted average number of common shares and dilutive common share equivalents outstanding. During periods when common stock equivalents, if any, are anti-dilutive they are not considered in the computation.

Recent pronouncements
The Company has evaluated all the recent accounting pronouncements through ASU No. 2011-03 and believes that none of them will have a material effect on the Company’s financial statement.

NOTE 2 – GOING CONCERN
 
The accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the recoverability of assets and the satisfaction of liabilities in the normal course of business. As noted above, the Company is in the development stage and, accordingly, has not yet generated revenues from operations. Since its inception, the Company has been engaged substantially in financing activities and developing its business plan and incurring start up costs and expenses. As a result, the Company incurred accumulated net losses from Inception (April 6, 2010) through the period ended March 31, 2011 of ($82,246). In addition, the Company’s development activities since inception have been financially sustained through equity financing.
 
The ability of the Company to continue as a going concern is dependent upon its ability to raise additional capital from the sale of common stock and, ultimately, the achievement of significant operating revenues. These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classification of liabilities that might result from this uncertainty.


 
8

 

NOTE 3 – FIXED ASSETS

Fixed assets consisted of the following as of:

   
March 31,
   
December 31,
 
   
2011
   
2010
 
Computer equipment
  $ 7,495     $ 2,118  
Computer software
    279       -  
Accumulated depreciation
    (1,000 )     (382 )
    $ 6,774     $ 1,736  

During the three months ended March 31, 2011, the Company recorded depreciation expense of $617.

NOTE 4 – WEBSITE

Website consisted of the following as of:

   
March 31,
   
December 31,
 
   
2011
   
2010
 
Website
  $ 250     $ 250  
Accumulated depreciation
    (62 )     (42 )
    $ 188     $ 208  

During the three months ended March 31, 2011, the Company recorded depreciation expense of $20.

NOTE 5 – TRADEMARK

Trademarks consisted of the following as of:

   
March 31,
   
December 31,
 
   
2011
   
2010
 
Trademarks
  $ 975     $ 975  
Accumulated amortization
    -       -  
    $ 975     $ 975  

During the three months ended March 31, 2011, the Company recorded amortization expense of $0.


 
9

 

NOTE 6 – LINE OF CREDIT – RELATED PARTY

Line of credit consists of the following at:

   
March 31,
2011
   
December 31,
2010
 
Revolving credit line due to an officer and director of the Company, unsecured, 6% interest, due in July 2013
  $ 10,000     $ 4,000  
                 
    $ 10,000     $ 4,000  

On July 27, 2010, the Company executed a line of credit in the amount of $20,000 with Steven Subick, a shareholder and Officer of the Company.  The line of credit carries an annual interest rate of 6% and has a term of three year, at which any outstanding balance is due in full. As of March 31, 2011, an amount of $10,000 had been used for general corporate purposes with a remaining balance of $10,000 available.

During the three months ended March 31, 2011, interest expense was $126.

NOTE 7 – STOCKHOLDERS’ EQUITY
 
The Company is authorized to issue 100,000,000 shares of its $0.001 par value common stock and 10,000,000 shares of its $0.001 par value preferred stock.

On February 23, 2011, the Company effected a 8-for-1 forward stock split of its $0.001 par value common stock.

All shares and per share amounts have been retroactively restated to reflect the split discussed above.

Common Stock
 
On April 6, 2010, the Company issued its sole officer and director of the Company 10,000,000 shares of its $0.001 par value common stock at a price of $0.001 per share for cash of $12,500.
 
On April 6, 2010, the Company issued 544,000 shares of its common stock toward legal fees at a value of $0.013 per share.  The shares were valued with the fair value of the services rendered.
 
On February 18, 2010, Company issued 4,800,000 shares of its common stock at a price of $0.013 per share for cash of $60,000.

During the three months ended March 31, 2011, there have been no other issuances of common stock.


 
10

 

NOTE 8 – WARRANTS AND OPTIONS

As of March 31, 2011, there were no warrants or options outstanding to acquire any additional shares of common stock.

NOTE 9 – RELATED PARTY TRANSACTIONS

During the three months ended March 31, 2011, the Company received a total of $6,000 from Steven Subick, a shareholder and Officer of the Company, as a draw on the line of credit.

During the three months ended March 31, 2011, the Company had consulting expenses totaling $400 for a director of the Company which was recorded to professional fees.

NOTE 10 – MATERIAL AGREEMENTS

On March 24, 2011, the Company, entered into a Share Exchange Agreement with Oraco Resources, Inc., a Canadian company (“ORI”) to acquire 100% of ORI’s outstanding common stock in exchange for 15,001,500 shares of common stock, concurrent with the Closing.  Additionally, the agreement sets forth conditions that the Company shall have obtained a cancellation of 10,000,000 shares of common stock.  The agreement with ORI, upon closing, will provide the Company with the ownership of 100% of ORI, which is involved in the diamond, gold, minerals and natural resources and exploration.

On March 24, 2011, the Company, entered into a Share Exchange Agreement with JYORK Industries Inc. Ltd., a Sierra Leone company (“JYORK”) to acquire 100% of JYORK’s outstanding common stock in exchange for 3,000,000 shares of common stock, concurrent with the Closing.  The agreement with JYORK, upon closing, will provide the Company with the ownership of 100% of JYORK, which is involved in the diamond, gold, minerals and natural resources and exploration.

NOTE 11 – SUBSEQUENT EVENTS

On April 28, 2011, the Company entered into an Addendum No. 1 (“Addendum”) to the Share Exchange Agreements dated March 24, 2011 with Oraco Resources, Inc., a Canadian company (“ORI”) and JYORK Industries Inc. Ltd., a Sierra Leone company (“JYORK”).  Pursuant to the Addendum the effective date was extended from April 8, 2011 to May 10, 2011 to complete the conditions set forth in the Merger Agreement.

On April 29, 2011, the Company formed a wholly-owned subsidiary, Merculite Distributing, Inc., a Nevada corporation (“Merculite”).

On May 6, 2011, we completed the spin-off (the “Spin-Off’) of the Company, and Merculite.  Prior to the Spin-Off, Merculite was a wholly-owned subsidiary of the Company.  In connection with the Spin-Off, the Company entered into the following Agreements (collectively, the “Spin-Off Agreements”):


 
11

 

·  
a Separation and Distribution Agreement that sets forth the arrangements among the Company and Meculite regarding the principal transactions to separation, and that governs the relationship of the Company and Merculite after the Spin-Off;

·  
Trademark License and Royalty Agreement that sets forth the arrangements among the Company and Merculite to assign the Sterilite Solutions trademark to Merculite

The Company and Merculite entered into a definitive Distribution Agreement governing the terms and conditions of the Spin-Off. The Spin-Off will be accomplished by the distribution by the Company of all shares of Merculite owned by it, among the shareholders of the Company on a pro rata basis. Each shareholder of the Company of record on May 6, 2011, the Distribution Record Date, will be distributed one share of Merculite common stock for each share of the Company stock owned by them.

The Company and Merculite entered into a Trademark Assignment and Acquisition Agreement, whereby the Company irrevocably assigns the Sterilite Solutions Mark in connection with the manufacturing, sub-contract manufacturing, production, marketing, promotion, distribution and sale of cleaning/neutralizing product.  The Company acknowledges that Merculite will have the exclusive right to ownership and use of the trademarks owned by the Company in lieu of any of the Marks on the product.


 
12

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

This Quarterly Report on Form 10-Q contains forward-looking statements and involves risks and uncertainties that could materially affect expected results of operations, liquidity, cash flows, and business prospects.  These statements include, among other things, statements regarding:
 
o  
our ability to diversify our operations;
 
o  
our ability to attract key personnel;
 
o  
our ability to operate profitably;
 
o  
our ability to efficiently and effectively finance our operations, and/or purchase orders;
 
o  
inability to achieve future sales levels or other operating results;
 
o  
inability to raise additional financing for working capital;
 
o  
inability to efficiently manage our operations;
 
o  
the inability of management to effectively implement our strategies and business plans;
 
o  
the unavailability of funds for capital expenditures and/or general working capital;
 
o  
the fact that our accounting policies and methods are fundamental to how we report our financial condition and results of operations, and they may require management to make estimates about matters that are inherently uncertain;
 
o  
deterioration in general or regional economic conditions;
 
o  
changes in U.S. GAAP or in the legal, regulatory and legislative environments in the markets in which we operate;
 
o  
adverse state or federal legislation or regulation that increases the costs of compliance, or adverse findings by a regulator with respect to existing operations;
 

as well as other statements regarding our future operations, financial condition and prospects, and business strategies.  These forward-looking statements are subject to certain risks and uncertainties that could cause our actual results to differ materially from those reflected in the forward-looking statements.  Factors that could cause or contribute to such differences include, but are not limited to, those discussed in this Quarterly Report on Form 10-Q, if any and in particular, the risks discussed under the heading “Risk Factors” in Part II, Item 1A and those discussed in other documents we file with the Securities and Exchange Commission.  We undertake no obligation to revise or publicly release the results of any revision to these forward-looking statements.  Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements.

 
13

 

References in the following discussion and throughout this quarterly report to “we”, “our”, “us”, “Oraco”, “the Company”, and similar terms refer to Oraco Resources, Inc. unless otherwise expressly stated or the context otherwise requires.

Business Development

Oraco Resources, Inc., is a development stage company incorporated in the State of Nevada in April of 2010. In February of 2011, we changed our name from Sterilite Solutions, Corp., to Oraco Resources, Inc. We were formed to engage in the business of distributing and manufacturing cleaning/sterilization solutions to consumers, public institutions and distributors of cleaning/janitorial supplies which are provided to us by Integrated Environmental Technologies, Ltd.

Since our inception on April 6, 2010 through March 31, 2011, we have not generated any revenues and have incurred a net loss of $82,246. Since April of 2010, our only business activity was the formation of our corporate entity, the development of our business model, the acquisition of our Sterilite Solutions, the internal testing of solutions,  and securing a trademark for our private label solution (Sterilite Solutions™).

Our business plan focused on building Oraco Resources, Inc., into the premier provider for non-caustic, green cleaning/sterilization solutions which would be beneficial for both private consumers as well as public sectors, focusing on various institutional and agricultural industries, including solutions for the mining industries. Recent events have shifted the focus of our business and we are attempting to integrate the application of our former business model to mining industry.

More recently our focus has been on determining the efficacy of our Sterilite Solution on neutralizing the effects of mercury contamination resulting from the amalgamation process to extract gold from ore.

OUR BUSINESS

Business Development Summary

Oraco Resources, Inc. is a development stage company incorporated in the State of Nevada in April of 2010. We were formed to engage in the business of the sales and distribution of a non-caustic, green cleaning and sterilization solutions which would be beneficial for both private consumers as well as public sectors, focusing on various institutional and agricultural industries. The company is intending to provide one of the first non-caustic cleaning solutions using technology and product developed by Integrated Environmental Technologies, Ltd. (IET), EcaFlo® Anolyte (EPA Registration No. 82341). We have launched our initial website, which is designed to provide information of our product as well as provide contact information for prospective customers. Upon further development, we intend to provide online sales capability, as well as multi-media based product demonstrations. We commenced operation in April of 2010 through the posting of our website (www.sterilitesolutions.com).

 
14

 

On February 17, 2011, we completed our initial public offering through the sale of 600,000 shares of common stock, resulting in gross proceeds of $60,000. Our Registration Statement on Form S-1 (File No. 333-167607), related to our initial public offering, was declared effective by the SEC on September 22, 2010. A total of 600,000 shares of common stock were registered with the SEC with an aggregate offering price of $60,000. All of these shares were registered on our behalf.

On February 23, 2011, we changed our name from Sterilite Solutions, Corp. to Oraco Resources, Inc. The name change occurred as a result of a majority of the stockholders executing a consent approving the Board of Directors recommendation to change the Registrant’s name. In addition, we changed our address to 605 West Knox Road, Suite 102, Tempe, Arizona 85284.

On February 23, 2011, the Board of Directors resolved to effect an eight (8) to one (1) forward split of our common stock outstanding as of February 24, 2011. The number of shares of common stock issued and outstanding prior to the forward split was 1,918,000. Immediately after the forward split, the number of shares issued and outstanding increased to 15,344,000.

On March 24, 2011, we entered into a Share Exchange Agreement with Oraco Resources, Inc., a Canadian company (“ORI”), whereby we agreed to issue 15,001,500 shares of our restricted common stock in exchange for all of the issued and outstanding Class A Shares of ORI. Pursuant to the agreement the closing of the transaction was anticipated to take place on or before April 8, 2011. The acquisition, upon closing, would provide us with ownership of 100% of ORI.

Additionally, on March 24, 2011, we entered into another Share Exchange Agreement with JYORK Industries Inc. Ltd., a Sierra Leone company (“JYORK”), whereby we agreed to issue 3,000,000 shares of our restricted common stock in exchange for all of the issued and outstanding shares of JYORK. Pursuant to the agreement the closing of the transaction was anticipated to take place on or before April 8, 2011. The acquisition, upon closing, would provide us with ownership of 100% of JYORK.

Both the ORI and JYORK share exchange agreements mentioned above will be collectively referred to as the “Agreements”.

Subsequent Events

On April 28, 2011, we entered into an Addendum No. 1 (“Addendums”) to the Share Exchange Agreement and Plan of Reorganization dated March 7, 2011 (“Original Agreement”) between among ORI and JYORK. Pursuant to each Addendum the effective date was extended from April 8, 2011 to May 10, 2011 to complete the conditions set forth in the Original Agreement.

On April 29, 2011, the Company formed a wholly-owned subsidiary, Merculite Distributing, Inc., a Nevada corporation (“Merculite”).


 
15

 

On May 6, 2011, we completed the spin-off (the “Spin-Off’) of the Company, and Merculite.  Prior to the Spin-Off, Merculite was a wholly-owned subsidiary of the Company.  In connection with the Spin-Off, the Company entered into the following Agreements (collectively, the “Spin-Off Agreements”):

·  
a Separation and Distribution Agreement that sets forth the arrangements among the Company and Meculite regarding the principal transactions to separation, and that governs the relationship of the Company and Merculite after the Spin-Off;

·  
Trademark License and Royalty Agreement that sets forth the arrangements among the Company and Merculite to assign the Sterilite Solutions trademark to Merculite

The Company and Merculite entered into a definitive Distribution Agreement governing the terms and conditions of the Spin-Off. The Spin-Off will be accomplished by the distribution by the Company of all shares of Merculite owned by it, among the shareholders of the Company on a pro rata basis. Each shareholder of the Company of record on May 6, 2011, the Distribution Record Date, will be distributed one share of Merculite common stock for each share of the Company stock owned by them.

The Company and Merculite entered into a Trademark Assignment and Acquisition Agreement, whereby the Company irrevocably assigns the Sterilite Solutions Mark in connection with the manufacturing, sub-contract manufacturing, production, marketing, promotion, distribution and sale of cleaning/neutralizing product.  The Company acknowledges that Merculite will have the exclusive right to ownership and use of the trademarks owned by the Company in lieu of any of the Marks on the product.

How We Plan To Generate Revenue

Oraco’s plan of revenue generation is based up the marketing and sales of our private labeled product Sterilite Solutions™. Our plan is to market our product through our website (www.sterilitesolutions.com), as well as through personal relationship development and on-site sales presentations and demonstrations. Through our corporate officer’s personal contacts in the service and industrial industries, our intention is to seek opportunities for the trial use of our product in industries which the sterilization capability of our product would be useful, “green” alternative to sterilization methods currently being used. We are focusing on industries related to health and hospitality as well as agricultural and mining. Recently we commenced discussions with a mining operation in a third world country, in anticipation of selling a version of our product for purposes of neutralizing the impact of mercury utilized in the mining operations.


 
16

 

Going Concern

The financial statements included in this filing have been prepared in conformity with generally accepted accounting principles that contemplate the continuance of the Company as a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. However, the Company is in the development stage and, accordingly, has generated minimal revenues from operations. As shown on the accompanying financial statements, the Company has incurred a net loss of $82,246 for the period from inception (December 17, 2009) to March 31, 2011. These conditions raise substantial doubt about the Company’s ability to continue as a going concern.

The future of the Company is dependent upon its ability to obtain financing and upon future profitable operations from the development of its business opportunities.

Results of Operations

Revenues

In this period ended March 31, 2011, we did not generate any revenues. Since our inception on December 17, 2009 through March 31, 2011, we did not generate any revenues.

Expenses

Operating expenses totaled $41,123 during the three months ended March 31, 2011.  Operating expenses consisted primarily of professional fees in the three ended March 31, 2011.

Professional fees totaled $40,337 during the three months ended March 31, 2011.

Depreciation and amortization expenses totaled $637 during the three months ended March 31, 2011.

General and administrative expenses totaled $149 during the three months ended March 31, 2011.

Liquidity and Capital Resources
 
The following table summarizes total current assets, total current liabilities and working capital at March 31, 2011 compared to December 31, 2010.

 
March 31,
2011
December 31,
2010
Increase / (Decrease)
$
%
         
Current Assets
$31
$93
$(62)
(66%)
         
Current Liabilities
$214
$20,714
$(20,500)
(98%)
         
Working Capital (deficit)
$(183)
$(20,621)
$(20,438)
(99%)


 
17

 

Liquidity is a measure of a company’s ability to meet potential cash requirements.  We have historically met our capital requirements through the issuance of stock and by borrowings.  In the future, we anticipate we will be able to provide the necessary liquidity we need by the revenues generated from the sales of our products.

Since inception, we have financed our cash flow requirements through issuance of common stock and related party notes payable. As we expand our activities, we may, and most likely will, continue to experience net negative cash flows from operations, pending receipt of listings or some form of advertising revenues. Additionally, we anticipate obtaining additional financing to fund operations through common stock offerings, to the extent available, or to obtain additional financing to the extent necessary to augment our working capital. In the future we need to generate sufficient revenues from product sales in order to eliminate or reduce the need to sell additional stock or obtain additional loans. There can be no assurance we will be successful in raising the necessary funds to execute our business plan.

We anticipate that we will incur operating losses in the next twelve months. Our lack of operating history makes predictions of future operating results difficult to ascertain.  Our prospects must be considered in light of the risks, expenses and difficulties frequently encountered by companies in their early stage of development. Such risks for us include, but are not limited to, raise sufficient capital to retain the services of well seasoned professionals to incur our probability of success.  There can be no assurance that we will be successful in addressing such risks, and the failure to do so can have a material adverse effect on our business prospects, financial condition and results of operations.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

Item 3. Quantitative and Qualitative Disclosure About Market Risk

This item in not applicable as we are currently considered a smaller reporting company.

Item 4T. Controls and Procedures
 
Evaluation of Disclosure Controls and Procedures

Our Chief Executive Officer and Chief Financial Officer, Bradley Rosen and Donna S. Moore, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) as of the end of the period covered by this Report.  Based on that evaluation and assessment, Mr. Rosen and Mrs. Moore concluded that our disclosure controls and procedures are designed at a reasonable assurance level and are effective to provide reasonable assurance that information we are required to disclose in the reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our chief executive officer and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

 
18

 

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting that occurred during our most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II—OTHER INFORMATION

Item 1.               Legal Proceedings.

From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. We are not presently a party to any material litigation, nor to the knowledge of management is any litigation threatened against us, which may materially affect us.
Item 1A. Risk Factors

Information about risk factors for the three months ended March 31, 2011, does not differ materially from that set forth in Part I, Item 1A, of Oraco’s 2010 Annual Report on Form 10-K.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

Use of Proceeds

On June 17, 2010 we filed a Registration Statement with the Securities and Exchange Commission wherein we registered 5,344,000 shares of our common stock. Our Registration Statement became effective on September 22, 2010. On February 18, 2011, we completed our offering for 4,800,000 shares of our common stock, resulting in gross proceeds of $60,000. The common stock sold in our initial public offering to 79 investors was issued on February 17, 2011. 544,000 additional shares were registered per the terms of the Retainer Agreement with our counsel, Stoecklein Law Group.

The amount of expenses incurred in connection with the issuance and distribution of the securities as of the date of this report was $9,000, of which $5,000 was legal fees, $3,000 was audit fees, and $1,000 was accounting fees.

The net offering proceeds to the issuer after deducting the total expenses is $42,000.

During the three months ended March 31, 2011, we spent $975 in registering a trade name with the United States Patent Office, $1,086 in general and administrative expenses, and professional fees totaling $59,776.  The professional fees consisted of accounting fees of $5,850, consulting fees of $400, edgar filing fees of $6,986 and legal fees of $45,540.

Issuer Purchases of Equity Securities

We did not repurchase any of our equity securities from the time of our inception on December 17, 2009 through the period ended March 31, 2011.


 
19

 

Item 5. Other Information.

On May 6, 2011, we completed the spin-off (the “Spin-Off’) of Oraco Resources, Inc. (“Oraco”), and Merculite Distributing, Inc., a Nevada corporation (“Merculite”). Prior to the Spin-Off, Merculite was a wholly-owned subsidiary of Oraco. As indicated previously, Oraco Resources was formerly known as Sterilite Solutions prior to its name change. In connection with the Spin-Off, Oraco entered into the following Agreements (collectively, the “Spin-Off Agreements”):

·  
a Separation and Distribution Agreement that sets forth the arrangements among Oraco and Meculite regarding the principal transactions to separation, and that governs the relationship of Oraco and Merculite after the Spin-Off;

·  
Trademark License and Royalty Agreement that sets forth the arrangements among Oraco and Merculite to assign the Sterilite Solutions trademark to Merculite

Oraco and Merculite entered into a definitive Distribution Agreement governing the terms and conditions of the Spin-Off. The Spin-Off will be accomplished by the distribution by Oraco of all shares of Merculite owned by it, among the shareholders of Oraco on a pro rata basis. Each shareholder of Oraco of record on May 6, 2011, the Distribution Record Date, will be distributed one share of Merculite common stock for each share of Oraco stock owned by them.

Oraco and Merculite entered into a Trademark Assignment and Acquisition Agreement, whereby Oraco irrevocably assigns the Sterilite Solutions Mark in connection with the manufacturing, sub-contract manufacturing, production, marketing, promotion, distribution and sale of cleaning/neutralizing product. Oraco acknowledges that Merculite will have the exclusive right to ownership and use of the trademarks owned by Oraco in lieu of any of the Marks on the product.


 
20

 

Item 6. Exhibits.

     
Incorporated by reference
Exhibit
Number
Exhibit Description
Filed
herewith
Form
Period
ending
Exhibit
Filing date
2.1
Share Exchange Agreement and Plan of Reorganization between ORACO and ORI, dated March 7, 2011.
 
8-K
   
3/28/11
2.2
Share Exchange Agreement and Plan of Reorganization between ORACO and JYORK, dated March 7, 2011.
 
8-K
   
3/28/11
2.3
Addendum No.1 to Share Exchange Agreement and Plan of Reorganization between ORACO and ORI, dated April 28, 2011.
 
8-K
   
4/28/11
2.4
Addendum No.1 to Share Exchange Agreement and Plan of Reorganization between ORACO and JYORK, dated April 28, 2011.
 
8-K
   
4/28/11
2.5
Separation and Distribution Agreement between Oraco Resources, Inc. and Merculite Distributing, Inc., dated May 6, 2011.
 
10-Q
3/31/11
2.5
5/17/11
2.6
Trademark Assignment and Acquisition Agreement between Oraco Resources, Inc., and Merculite Distributing, Inc., dated May 6, 2011.
 
10-Q
3/31/11
2.6
5/17/11
31.1
Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act
X
       
31.2
Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act
X
       
32.1
Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act
X
       
32.2
Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act
X
       

 
SIGNATURES
 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 


ORACO RESOURCES, INC.
(Registrant)

By: /S/ Bradley Rosen              
     Bradley Rosen, Chief Executive Officer
      (Principal Executive Officer)


Date: July 20, 2011
 
 
21